Shock Global Clinical Trials Review, H2, 2012

Print  | 

Hyderabad,AndhraPradesh, July 30, 2012 — GlobalData’s clinical trial report, “Shock Global Clinical Trials Review, H2, 2012″ provides data on the Shock clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Shock. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Shock. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

For further information visit http://www.reportreserve.com/report/shock-global-clinical-trials-review-h2-2012-report-555448

Other press releases from ReportReserve

• Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness - October 31st, 2012
• Gastrointestinal Disorders Therapeutics Market to 2018 - October 31st, 2012
• Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 - October 31st, 2012
• Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 - Next Generation Quadrivalent Vaccines to Dominate the Market by Offering Broader Protection via Single Dose - October 31st, 2012
• Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market - October 31st, 2012